May 19th, 2012
POZEN Presents Phase 1 Data at Digestive Disease Week 2012
SAN DIEGO--(CRWENewswire)--POZEN Inc. (NASDAQ:POZN), a pharmaceutical company committed to transforming medicine that transforms lives, presented data today from a Phase 1 study that found
May 19th, 2012
ALLEGAN, Mich., May 18, 2012 (CRWENewswire) -- Perrigo Company (Nasdaq:PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) for Lansoprazole capsul
May 15th, 2012
Highlights how Codexis platform enables breakthrough biocatalytic processes
REDWOOD CITY, Calif.--(CRWENewswire)--Codexis, Inc. (Nasdaq:CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmac
May 15th, 2012
NEW YORK, May 15, 2012 (CRWENewswire)-- Capital Trust, Inc. (NYSE:CT) (the "Company") announced today that its Board of Directors (the "Board") has formed a Special Committee of the Board comprised of independent directors (the "Special Committee")
May 14th, 2012
BEIJING, May 14, 2012 (CRWENewswire) -- China Shen Zhou Mining & Resources, Inc. ("China Shen Zhou" or the "Company") (Amex:SHZ), a Company engaged in the exploration, development, mining and processing of fluorite, barite, zinc, copper, and ot
May 13th, 2012
ORLANDO, Fla., May 11, 2012 (CRWENewswire Fri, May 11, 2012) -- Gencor Industries, Inc., (Nasdaq:GENC) announced today that revenue for the second quarter ended March 31, 2012 increased 16% to $19.3 million from $16.7 million for the quarter ended